Skip to content

Clinical trials

Observational Cognitive Dysfunction trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Observational Country / region: Switzerland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20113
20131
20141
20173
20182
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Basel, Switzerland4
Cantonal Hospital of St. Gallen2
Andreas Monsch1
Claudio Gobbi1
Insel Gruppe AG, University Hospital Bern1
Swiss Paraplegic Research, Nottwil1
Swiss SOS Study Group1
University of Bern1
Zurich University of Applied Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction13
Alzheimer Disease3
Cognition Disorders3
Multiple Sclerosis3
Fatigue2
Stroke2
Atrial Fibrillation1
Dementia1
Dyspnea1
Emergence Delirium1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.